141 related articles for article (PubMed ID: 3494425)
1. Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.
Jones C; Stevens DL; Ojo O
Antimicrob Agents Chemother; 1987 Feb; 31(2):144-7. PubMed ID: 3494425
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
Hamilton DJ; Ulness BK; Baugher LK; Counts GW
J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
[TBL] [Abstract][Full Text] [Related]
3. Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.
Coll PF; Ausina VR; Vernis JV; Mirelis BO; Prats GP
Eur J Clin Microbiol; 1984 Oct; 3(5):424-6. PubMed ID: 6238821
[TBL] [Abstract][Full Text] [Related]
4. Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
Escamilla J; Kilpatrick ME; Ugarte HF
J Clin Microbiol; 1986 Jan; 23(1):205-6. PubMed ID: 3486190
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
6. Microbiological perspectives of co-trimoxazole.
Bauernfeind A; Hörl G; Przyklenk B
Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Pseudomonas species to carbenicillin and trimethoprim-sulfamethoxazole.
Hill SF; Haldane DJ; Ngui-Yen JH; Smith JA
J Clin Microbiol; 1985 Sep; 22(3):465-6. PubMed ID: 3930567
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity testing with trimethorpim-sulphamethoxazole.
Bushby SR
Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
[No Abstract] [Full Text] [Related]
10. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
11. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
12. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
Bushby SR
J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
[No Abstract] [Full Text] [Related]
13. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
King CH; Shlaes DM; Dul MJ
J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim-sulfamethoxazole.
Ferguson RW; Weissfeld AS
J Clin Microbiol; 1984 Jan; 19(1):85-6. PubMed ID: 6418766
[TBL] [Abstract][Full Text] [Related]
15. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
Barry AL; Jones RN; Gavan TL
J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
[TBL] [Abstract][Full Text] [Related]
16. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
Küchler R; Koch UJ
Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
[No Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
Fu KP; Kimble EF; Coldreck RJ; Konopka EA
Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
[TBL] [Abstract][Full Text] [Related]
18. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
Najjar A; Murray BE
Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
[TBL] [Abstract][Full Text] [Related]
19. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G; Wiedmer E
Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
[No Abstract] [Full Text] [Related]
20. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
Yeldandi V; Strodtman R; Lentino JR
J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
